Tailored chemotherapy: Innovative deep‐learning model customizing chemotherapy for high‐grade serous ovarian carcinoma
Open Access
- 7 September 2024
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 14 (9) , e1774
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian CarcinomaCancers, 2021
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 2021
- TP53 mutations in epithelial ovarian cancerTranslational Cancer Research, 2016
- InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancerOncogene, 2016
- Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeJournal of Cancer, 2016
- Whole–genome characterization of chemoresistant ovarian cancerNature, 2015
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic AnalysisPLOS Medicine, 2015
- The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional AnalysisPLOS ONE, 2014